Jaguar Health, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
JAGX on Nasdaq
Location
200 Pine Street Suite 400, San Francisco, CA

There are no Buy or Sell transactions made by insiders since 9/17/2023

Jaguar Health, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Micek Director $2.42K Aug 14, 2023
James J. Bochnowski Director $2.37K Aug 14, 2023
Anula Jayasuriya Director $2.11K Jul 1, 2023
Jonathan B. Siegel Director $2.1K Aug 14, 2023
Gregory J. Divis Director $364 May 18, 2022
Lisa A. Conte CEO and President, Director $138 May 17, 2024
Pravin R. Chaturvedi Chief Scientific Officer $38.00 May 17, 2024
Jonathan S. Wolin Chief of Staff, CCO & GC $34.00 May 17, 2024
Steven R. King Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary $34.00 May 17, 2024
Carol R. Lizak Chief Financial Officer $22.00 May 17, 2024

Recent Insider Transactions by Companies or Individuals for Jaguar Health, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.